NICE is trading 10.56% lower at $95.05 after its November 4, 2026, Q3 report; weaker GAAP earnings and planned workforce cuts best explain the decline despite adjusted beats. - Adjusted EPS of $2.84 and revenue of $790.7 million beat analyst estimates; NICE raised its full-year adjusted EPS outlook to $11.12–$11.32. - GAAP diluted EPS fell to $1.60 from $2.29 a year earlier, and NICE plans to reduce its global workforce by about 5%.